The data management approach of the ADRC is an integrated statistics, data management and data protection solution. The Data Management Core receives, stores, catalogues, tracks and integrates data generated by the Cores and Projects in the ADRC and provides expert advice for the statistical analysis of data components or integrations. At the center of the data management core for the ADRC is the overarching aim to meet the needs of NACC at every level, from data acquisition to data storage, formatting, and reporting. Implementation of this data management system is a dynamic process that aims to meet the growing and diverse needs of the ADRC. These dynamic changes include readiness to respond to changes in not only national standards for research data acquisition and maintenance (e.g., HIPAA) but also to the necessary changes and growth that occurs to NACC. Every effort has been made to systematize and unify all data collection by the clinical and neuropathology cores. This unification serves to enhance the activities of the cores, the access to the generated data by the projects, and the accuracy and ease with which data from the cores can and is reported to NACC. Thus, all ADRC clinical core sites collect a common data set in a common and identical format. This data (Standardized Clinical Dementia Evaluation (SCDE)) is completed by investigators at each site and completed forms are then input into the Data Warehouse by the Data Management core personnel. The Data Warehouse provides for multiple levels of data integrity checking, including range and logic. Once the SCDE results have been input, generating a NACC report is designed to be a turn-key operation. Similarly, all data from the neuropathology core are coded onto CERAD neuropathology battery forms that are enhanced to guarantee inclusion of all NACC neuropathology variables. Again these data are input into the Data Warehouse where data integrity is highly controlled allowing for accurate data for research use and for NACC reporting. The Data Warehouse is also designed to accommodate more idiosyncratic data sets such as those generated by Projects 1-3. By design, all data input into the Warehouse MUST include a set of common identifier fields. The use of these common identifier fields allows for the integration and cross-fertilization of project and core based data. All of the projects in this proposal will also require considerable statistical data analysis and a high level of statistical analytic sophistication. This statistical analysis advice is provided by Dr. Schmeidler who has been the statistical expert for the ADRC for over 14 years. Dr. Schmeidler is not only familiar with all of the data collected and analyzed by members of the ADRC in the past, but he has been actively involved in the planning of the currently proposed studies and in their experimental design.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005138-22
Application #
7309674
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-04-01
Budget End
2007-03-31
Support Year
22
Fiscal Year
2006
Total Cost
$64,688
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Silverman, Jeremy M; Schmeidler, James (2018) Outcome age-based prediction of successful cognitive aging by total cholesterol. Alzheimers Dement 14:952-960
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Warren, Noel A; Voloudakis, Georgios; Yoon, Yonejung et al. (2018) The product of the ?-secretase processing of ephrinB2 regulates VE-cadherin complexes and angiogenesis. Cell Mol Life Sci 75:2813-2826
Tsartsalis, Stergios; Xekardaki, Aikaterini; Hof, Patrick R et al. (2018) Early Alzheimer-type lesions in cognitively normal subjects. Neurobiol Aging 62:34-44
Ridge, Perry G; Karch, Celeste M; Hsu, Simon et al. (2018) Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome Med 10:4
Pimenova, Anna A; Raj, Towfique; Goate, Alison M (2018) Untangling Genetic Risk for Alzheimer's Disease. Biol Psychiatry 83:300-310
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307

Showing the most recent 10 out of 555 publications